DSKYF (Daiichinkyo Co) Beginning Cash Position : $-0 Mil (As of Mar. 2025)

View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co Beginning Cash Position?

Daiichinkyo Co's Beginning Cash Position for the quarter that ended in Mar. 2025 was $-0 Mil.

Daiichinkyo Co's quarterly Beginning Cash Position declined from Sep. 2024 ($5,633 Mil) to Dec. 2024 ($4,601 Mil) and declined from Dec. 2024 ($4,601 Mil) to Mar. 2025 ($-0 Mil).

Daiichinkyo Co's annual Beginning Cash Position declined from Mar. 2023 ($4,956 Mil) to Mar. 2024 ($2,888 Mil) but then increased from Mar. 2024 ($2,888 Mil) to Mar. 2025 ($4,342 Mil).

Daiichinkyo Co Beginning Cash Position Historical Data

The historical data trend for Daiichinkyo Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co Beginning Cash Position Chart

Daiichinkyo Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Beginning Cash Position

Get a 7-Day Free Trial

3,902.38

3,209.28

4,956.28

2,888.15

4,341.81

Daiichinkyo Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															4,430.96	4,099.71	5,632.99	4,600.80	-0.01

Daiichinkyo Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Daiichinkyo Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Daiichinkyo Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (OTCPK:DSKYF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

DSNKY:USA 4568:Mexico 4568:Japan D4S:Germany

Address

3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426

Website

https://www.daiichisankyo.com

Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2023, approximately one third of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first US approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.